StonvexLoading…
StonvexStonvexStonvexCore line items from ORGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $18.92M | $31.28M | $28.80M | $0.00 |
Operating Income | $-259.09M | $-84.86M | $-54.88M | $-38.95M |
Net Income | $-249.70M | $-83.70M | $23.80M | $78.57M |
EPS (Diluted) | $-50.55 | $-17.54 | $0.17 | $0.55 |
Total Assets | $157.66M | $378.03M | $461.83M | $493.70M |
Total Liabilities | $53.45M | $39.66M | $39.33M | $116.80M |
Cash & Equivalents | $32.92M | $56.31M | $75.50M | $107.86M |
Free Cash Flow OCF − CapEx | $-63.00M | $-59.78M | $-162.54M | $-109.78M |
Shares Outstanding | 5.17M | 4.95M | 145.71M | 143.03M |